| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Tuan Tu Diep is Chief Development Officer at SKYE. Tuan Tu Diep's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $100K at current prices.
The SKYE filings lean toward selling, a net 19,574 shares.
Tuan Tu Diep has 6 Form 4 filings on record from February 2024 to March 2026, all as Chief Operating Officer at Skye Bioscience (SKYE), 2024–2026.
The 21 reported transactions were 11 option or other derivative awards, 7 dispositions back to the company, 2 open-market sales and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $98K.
The only open-market sale was 19,574 shares of SKYE at an average $4.99 on November 18, 2024, about $98K. Twelve months later SKYE was down 71%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | SKYE Skye Bioscience, Inc. | Chief Development Officer | Sell | 19,574 | $4.99 | $97,721.86 | -19.2% | -31.8% | -70.8% |